Skip to main content
Fig. 1 | Trials

Fig. 1

From: The role of exercise combined with tocilizumab in visceral and epicardial adipose tissue and gastric emptying rate in abdominally obese participants: protocol for a randomised controlled trial

Fig. 1

Flow of participants through the study. Any reasons for discontinuation or exclusion from analysis are reported. ET (Endurance exercise + tocilizumab), EP (Endurance exercise + saline (placebo)), RP (Resistance exercise + saline), NT (No-exercise control + tocilizumab), NP (No-exercise control + saline)

Back to article page

Trials

ISSN: 1745-6215